双膦酸盐用药患者口腔护理知情的牙医问卷设计与验证
Design and validation of a questionnaire to measure the knowledge and performance of dentists regarding dental considerations in patients receiving bisphosphonate
一项横断面研究于2021年7月至2021年1月期间在伊朗Kashan市开展,基于Web of Science、Scopus、PubMed等数据库文献检索及专家访谈,设计并初步验证了一份测量牙医双膦酸盐用药患者口腔护理相关知识与表现的问卷。最终版问卷共34题,其中知识模块27题、表现模块7题,由非概率便利抽样纳入110名参与 dentist。
Introduction
Bisphosphonates have been used since 1960 to manage many bone metabolic disorders such as Paget’s disease, multiple myeloma, bone metastases and more commonly osteoporosis. These drugs can be used orally and intravenously. The most commonly prescribed bisphosphonate is alendronic acid, which was among the 20 most prescribed drugs worldwide in 2003 with 17 million prescriptions [1,2,3,4,5]. The first side effect of these drugs was esophageal ulcers due to oral alendronic acid, which was explained by Groen in 1996. Also, Marx reported for the first time in 2003 a case of jaw osteonecrosis related to the consumption of bisphosphonates and used the term Bisphosphonate Related Osteonecrosis of the Jaw (BRONJ) to express it [1, 6, 7]. Since other drugs such as Denosumab and other anti-angiogenic drugs can also lead to osteonecrosis of the jaw, in 2014, the American Society of Maxillofacial Surgeons proposed to use the term Medication Related Osteonecrosis of the Jaw (MRONJ) for this condition [4, 8].
According to the definition of the American Society of Maxillofacial Surgeons, MRONJ is an exposed bone or can be probed through an intra- or extra-oral fistula that lasts more than 8 weeks in the jaw and face area of a patient with a history or taking anti-angiogenic drugs and without the history of radiotherapy or metastatic disease must remain stable [8].
The mechanism of action of bisphosphonates is not well known, but it seems that inhibiting the activity of osteoclasts by these drugs disrupts the bone remodelling cycle. This issue in the jawbone, which is in constant contact with the external environment and is subject to repeated micro-traumas, exposes them to the development of MRONJ complications [9, 10].
Bone exposure can occur spontaneously in a few cases and in more common cases following invasive dental procedures such as implant placement and endodontic surgery. This necrotic bone is painful and can become infected secondary. Swelling and redness of the mucous membrane, purulent secretions, sometimes along with fistula formation can reduce the patient’s quality of life. Patients often complain of bad taste, difficulty eating, pain and discomfort in the mouth. MRONJ can progress and lead to mandibular fracture, severe maxillary sinusitis, oral-sinus fistula and even an eye socket abscess. [3, 11]. The risk of developing MRONJ is higher in patients who take drugs intravenously [6].
Aggressive dental practices act as a risk factor in creating these lesions. Therefore, establishing optimal oral health before starting the treatment with the mentioned drugs, by reducing the risk of needing invasive dental measures during the treatment period, is effective in preventing complications. Dentists’ knowledge about this issue is also important in preventing the occurrence of this complication [4, 5]. The awareness of dentists in foreign studies such as Alhussain A et al.‘s study in Ontario and domestic studies such as Omran Haj-Mohammadi et al.‘s in Ardabil has been evaluated as moderate, and the need for more training has been expressed [6, 9].
There are few studies in which a standard and precise instrument in Persian language has been used to measure the awareness and performance of dentists regarding dental considerations in patients using bisphosphonates; Therefore, this study was conducted with the aim of designing and validating a questionnaire to measure the knowledge and performance of dentists regarding dental considerations in patients receiving bisphosphonates.
Materials and methods
Statistical population and sample
This cross-sectional descriptive study was conducted on a group of dentists between July and January 2021 after obtaining the ethics code number IR.KAUMS.MEDNT.REC.1400.083. The statistical population of this research includes general and specialist dentists who work in clinics, government, private and educational centers in Kashan city. According to the study of Omran Hajmohammadi and colleagues entitled “Awareness of dentists in Ardabil province regarding dental considerations of patients treated with bisphosphonate drugs”, it was observed that the level of awareness of dentists was good at 19.8% (P) [6]. Considering 95% confidence and 5% accuracy and population size N = 110 people, the minimum required sample was calculated as 77 people, which finally increased to 110 people to measure the reliability of the instrument structure which were selected by non-probability and easy sampling methods and were tested. All the participants gave informed consent to taking part in the study.
Measurement tool
We reviewed relevant scientific literature by searching reputable databases (Web of Science, Scopus, PubMed, Science Direct, ProQuest) using keywords [“knowledge”, “awareness”,” performance”, “practice”, “bisphosphonate”, “osteonecrosis”, “medication-related osteonecrosis of the jaw”, “MRONJ”] from 2010 onward and collected expert opinions via open-ended interviews. Based on the interview findings and search results, we then compiled and designed the initial research questions.
To design the questionnaire, first, articles and guidelines related to the studied subject and the factors for measuring awareness and performance were included in it. The initial questionnaire consisted of 45 questions; after examining and reviewing the questions, 9 questions were deleted or merged with each other, and the final questionnaire had two parts: measuring knowledge, including 27 questions, and performance, including 7 questions. The knowledge assessment part includes questions about the cases and methods of administration and mechanism of action of bisphosphonates, the risk of MRONJ complications, risk factors related to MRONJ complications, clinical and radiographic symptoms of MRONJ complications, and dental procedures related to MRONJ complications.
Then, the initial design of the questionnaire was given to two oral and maxillofacial surgeons to check validity and appearance, and the necessary corrections were made. After that, in order to measure the validity of the content, the questionnaire was given to 15 dental experts (2 maxillofacial surgeons, 3 pathologists, 2 oral and dental disease specialists, 2 endodontists, 2 periodontists, 1 prosthodontist, 2 restorative and cosmetic specialists, and 1 radiologist) and each of the questions were evaluated in terms of necessity, appropriateness, clarity and simplicity. Necessity was measured in a 3-option Likert form (including 1. not useful, 2. useful but unnecessary, and 3. necessary and useful), and CVR (content validity ratio) was calculated for each of the questions. Questions with CVR values less than 0.49 were excluded from the questionnaire.
$${CVR}=\frac{{ne}-N/2}{N/2}$$
ne: the number of people who gave the necessity a score of 3.
N: the total number of specialists (15 people).
A 4-point Likert scale was used to measure relevance, clarity and simplicity, and CVI (content validity index) was calculated for each of the questions. Questions with a CVI value of less than 0.7 were reviewed.
$${CVI}=\frac{{ne}}{N}$$
ne: the number of people who gave a score of 3 or 4 for appropriateness, clarity and simplicity.
N: the total number of specialists (15 people).
Exploratory factor analysis
Exploratory factor analysis and then confirmatory factor analysis were used to check construct validity and identify the factors in the questions. The basic assumptions of factor analysis include calculating the normality of the data using the Kolmogorov-Smirnov test, the Pearson correlation coefficient between the subscales and the entire questionnaire, and the Kaiser-Meyer-Olkin (KMO) and Bartlett’s sphericity tests are used to determine the adequacy of the data for factor analysis. Then, exploratory factor analysis was performed with the help of principal components, detailed diagramming and varimax rotation, and the variance explanation percentage was calculated for the knowledge and performance questions, and each question was weighted [12].
Confirmatory factor analysis
In order to confirm the exploratory structure, confirmatory factor analysis was used to test the model, in order to check the goodness of fit of the model with the research data, the indices related to the fit of the model presented in the table were used, which include the incremental fit index (IFI), Tucker-Lewis (TLI), comparative fit index (CFI) and normalized fit index (NFI). The closer the value of these indices is to 1, the better the fit, and the value of 0.9 has been determined as a good fit criterion. Another indicator is the root-mean-square error of approximation (RMSEA). Based on this index, values greater than 1 indicate a poor fit, values between 0.8 and 1 indicate an average fit, values between 0.5 and 0.8 indicate an acceptable fit, and also, in order to achieve a solid structure, it was decided to keep only questions in the final version that had a significant factor loading above 0.4 [13].
Tool reliability
In the next step, the questionnaire was given to 40 dentists, and its reliability was checked by dividing it into halves and calculating Cronbach’s alpha reliability coefficient. Cronbach’s alpha coefficient above 0.7 was considered acceptable. Also, the average variance extracted, or AVE (Average Variance Extracted) was used to evaluate the convergent validity. In simple words, Average Variance Extracted (AVE) quantifies the correlation between a construct and its measurement indicators. Higher AVE values indicate stronger construct fit. According to Fornell and Larcker, convergent validity is established when AVE exceeds 0.5. The internal consistency of this scale is using composite reliability or CR (Composite Reliability). Convergent validity exists when CR is greater than 0.7. Also, CR should be greater than AVE [14, 15].
$${CR}=\frac{{(\sum \lambda )}^{2}}{{(\sum \lambda )}^{2}+(\sum \varepsilon )}$$
$${AVE}=\frac{\sum {\lambda }^{2}}{n}$$
$$\alpha =\frac{k}{k-1}(1-\frac{{\sum }_{i=1}^{k}{\sigma }^{2}}{{\sigma }^{2}})$$
Results
Validity and reliability
After the face validity was confirmed by 2 oral and maxillofacial surgeons, a questionnaire including 3 parts (demographic information, knowledge questions, performance questions and clinical decision-making) was given to 15 dental experts to check content validity. After calculating CVR (Content Validity Ratio) and CVI (Content Validity Index), it was decided to remove or revise questions with CVR less than 0.49 and CVI less than 0.7. CVR and CVI awareness and performance questions are detailed in Table 1.
Considering the deletion of questions numbers 7 and 17, the questionnaire was given to 110 dentists, and exploratory and confirmatory analysis was done on them. The results of the exploratory analysis showed that the explanation percentage of the variance of the knowledge questionnaire was reported as 66.57%. Regarding the questionnaire related to performance, the variance explanation percentage was reported as 89.76%. Then, the questionnaire was given to 40 dentists, and its reliability was checked by dividing it into halves and calculating Cronbach’s alpha reliability coefficient. Cronbach’s alpha coefficient was calculated as 0.909 and 0.848 for performance questions Table 2.
Also, the AVE index for awareness and performance was 0.380 and 0.403, respectively. The CR index for awareness and performance was calculated as 0.925 and 0.817, respectively.
Confirmatory factor analysis
Figure 1 shows the first-order confirmatory factor analysis of the awareness questionnaire. The factor loadings of the questionnaire questions in each factor are shown in the figure. The fit indices of the initial model indicate the poor fit of the model. Therefore, he referred to the model correction indices, which showed that the correlation (covariance) of the error of question 1 with question 15, also, the error of question 2 with questions 27 and 4, the error of question 5 with 3, and the error of question 6 with 22 is significant. And by adding these correlations to the model, its fit improves significantly. Also, the examination of the estimated parameters in the initial model showed that question numbers 9,10,11 and 19 do not have a significant factor. Therefore, it should be removed from the model. In the final model, CFI, TLI, IFI, NFI, and RMSEA values are 0.899, 0.885, 0.902, 0.77, and 0.072, respectively, which indicates the optimal fit of the model.
First-order confirmatory factor analysis of the awareness questionnaire.
Figure 2 shows the first-order confirmatory factor analysis of the performance measurement questionnaire. The factor loadings of the questionnaire questions in each factor are shown in the figure. The fit indices of the initial model indicate a poor fit of the model, so they referred to the model correction indices, which showed that the correlation (covariance) of the error of question 5 with questions 7 and 8 is also significant. And by adding these correlations to the model, its fit improves significantly. In the final model, CFI, TLI, IFI, NFI, and RMSEA values are 0.977, 0.952, 0.978, 0.945, and 0.077, respectively, which indicates the optimal fit of the model.
First-order confirmatory factor analysis of the performance questionnaire.
Discussion
The present study is for the design and psychometry of a questionnaire to measure the awareness and performance of dentists in patients receiving bisphosphonates. The knowledge part includes questions related to cases and methods of administration, mechanisms of action of bisphosphonates, risk of MRONJ complications, risk factors related to MRONJ complications, clinical and radiographic symptoms of MRONJ, dental procedures related to MRONJ complications. While the study of Al-Maweri et al. in 2015, which is a researcher-made questionnaire related to the awareness of the same drug among dentists, includes two parts. In the first part, there are questions about the MRONJ complication, the therapeutic uses of bisphosphonates, the brand name, and the different types of this drug group. The questions of the second and third parts are also related to the clinical features of MRONJ complications and risk factors related to their occurrence, and finally, the therapeutic or preventive dental measures in patients consuming bisphosphonates [16]. Also, the study of Paula Baptistella de Lima and colleagues includes the examination of the general knowledge of dentists about bisphosphonates and the risk factors of BRONJ complications [17].
The study by K Gaballah et al. is also a cross-sectional descriptive study, and the questionnaire of this study consists of questions about the following items. The frequency of visits of patients using bisphosphonates to dentists, their understanding of the side effects of these drugs, the diagnosis of dental treatments that may require special considerations in patients using these drugs. And finally, knowledge of the optimal management of patients who seek dental treatments during or after the treatment period with this drug group [2].
After measuring and confirming the validity of the questionnaire of the present study by 15 expert dentists, its reliability was measured with the help of Cronbach’s alpha, which was at an acceptable level. In Yazdani et al.‘s study, the validity of a questionnaire similar to the present questionnaire was checked, corrected and confirmed by 10 faculty members, and the reliability of the questionnaire measured by Cronbach’s alpha was at an acceptable level [18].
In particular, it was shown that most patients taking bisphosphonates may not be familiar with the drug and its adverse side effects. This highlights the responsibility of dentists to educate about the oral complications caused by the use of bisphosphonates and the need for proper dental care for these patients. On the other hand, dentists’ lack of familiarity with the uses of this drug, such as the treatment of osteoporosis, hypercalcemia, Paget’s disease, multiple myeloma, and bone metastasis, prevents obtaining a correct and complete medical history from patients receiving the drug [19]. Alendronate sodium is one of the most commonly used oral bisphosphonates. Zolendronate is also one of the intravenous types of medicine [16, 20].
It is necessary for dentists to be aware of the different forms of this medicine and its uses, and to provide information about the side effects of bisphosphonates, especially osteonecrosis of the jaw associated with this drug group, to patients. Because if preventive measures are not implemented, the risk of BRONJ will increase significantly [2, 18, 21].
Similarly, Kholsa et al. and Lam et al. reported that the management of periodontal disease and oral health in patients who use bisphosphonates is very important, and they emphasized the need to inform about the risk of MRONJ and the importance of performing necessary dental procedures before starting the drug treatment period. Therefore, the present study includes questions about the cases and methods of prescribing bisphosphonates, their mechanism of action, risk factors related to the occurrence of MRONJ, clinical and radiographic symptoms of MRONJ, and dental procedures related to the occurrence of MRONJ [22, 23].
Dentists should know the mechanism of action of bisphosphonates due to their adverse effects: as a result of taking these drugs, due to the property of inhibiting angiogenesis, bone blood circulation is reduced, the function of osteoclasts is inhibited, and as a result, bone regeneration is disturbed. The knowledge of dentists about the properties and uses of bisphosphonates affects the correct way of obtaining the patient’s medical history [24]. Oral and dental surgeries, such as tooth extraction, are one of the main risk factors for BRONJ complications. Periodontal diseases and the use of artificial teeth are also considered as potential risk factors [25].
People who use bisphosphonates are more susceptible to BRONJ than people who do not use this drug. Also, these patients may seek dental care due to tooth or jaw pain without any obvious symptoms of treatment complications. If their symptoms do not resolve with routine dental and periodontal therapy, BRONJ should be considered as a differential diagnosis, even in the absence of exposed bone. Therefore, the role of general dentists in the prevention and early diagnosis of BRONJ cases cannot be overemphasized [24].
However, knowledge about appropriate clinical decisions for patients using drugs and the ability to recognize and treat stages of osteonecrosis are critical yet lacking. Even though dentists ask their patients about the use of systemic medications, many of them may ignore the information collected or not understand its clinical significance.
Limitation
The present study has several limitations. First, Because of the limited number of dentists, selecting a larger sample was not possible. second Although the questionnaire covers a wide range of aspects of knowledge and practice, it does not include areas related to risk communication and patient education strategies. In addition, clinical decision-making is assessed by seven items, which may not be sufficient to capture the complexity of real-world clinical scenarios. While more questions could have been included, limitations due to sample size and questionnaire capacity prevented their addition. It is recommended that future studies consider these items.
Conclusions
Dentists are often on the front line of dealing with patients receiving bisphosphonates, and any error in their performance can cause these patients to face many problems. Therefore, it is very important to measure the knowledge and performance of dentists regarding dental considerations in these patients. The present study was conducted with the aim of designing and validating a comprehensive questionnaire in Persian to measure the knowledge and performance of dentists regarding the dental considerations of patients receiving bisphosphonate. The mentioned questionnaire can be used in future research to investigate the knowledge and performance of dentists around the country.
The final questionnaire consists of 3 parts. The first part contains the dentist’s demographic information (age, gender, educational level, time since graduation from general education, participation in the retraining course around MRONJ and the service department). The second part includes questions related to measuring dentists’ awareness of dental considerations in patients receiving bisphosphonates. (Cases and methods of administration and mechanism of action of bisphosphonates, risk of MRONJ complications, risk factors related to MRONJ complications, clinical and radiographic symptoms of MRONJ complications, dental procedures related to MRONJ complications, and…). The third part includes the questions related to measuring the performance and clinical decision of dentists regarding dental considerations in patients receiving bisphosphonates (Experience of dealing with patients consuming bisphosphonates, treatment strategy for patients consuming bisphosphonates in various dental treatments).
Ethics
Ethics Committee of the Faculty of Medicine and Dentistry, Kashan University of Medical Sciences. The ethics code number IR.KAUMS.MEDNT.REC.1400.083.
References
Al-Eid R, Alduwayan T, Khuthaylah MB, Al Shemali M. Dentists’ knowledge about medication-related osteonecrosis of the jaw and its management. Heliyon. 2020;6:e04321.
Gaballah K, Hassan M. Knowledge and attitude of dentists on bisphosphonates use in the UAE: a descriptive cross-sectional study. Int Surg J. 2017;4:1398–404.
Hupp JR, Tucker MR, Ellis E. Contemporary Oral and Maxillofacial Surgery-E-Book: Contemporary Oral and Maxillofacial Surgery-E-Book: Elsevier Health Sciences; 2013.
Krishnan S, Shetty V, Shetty J, Babu GS, Rajeev T. Bisphosphonate-related osteonecrosis of the jaw: an enigma among medical practitioners. Indian J Med Paediatr Oncol. 2019;40:257–64.
Sturrock A, Preshaw P, Hayes C, Wilkes S. Attitudes and perceptions of GPs and community pharmacists towards their role in the prevention of bisphosphonate-related osteonecrosis of the jaw: a qualitative study in the North East of England. BMJ Open. 2017;7:e016047.
Hajmohammadi E, Sattarzadeh S, Amani F. Knowledge rate of dentists regarding dental consideration of bisphosphonate drug user patients. J Res Med Den Sci. 2015;3:194–8.
Heidari M, Maboudi A, Motevali S, Sobouti F, Moosazadeh M. Practice of oral and maxillofacial surgeons in bisphosphonates users in Tehran: brief report. Tehran Univ Med Sci J. 2019;76:762–6.
Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, et al. Definition of medication-related osteonecrosis of the jaw in 2014. Update. 2014;72:1938–56.
Alhussain A, Peel S, Dempster L, Clokie C, Azarpazhooh A. Knowledge, practices, and opinions of Ontario dentists when treating patients receiving bisphosphonates. J Oral Maxillofac Surg. 2015;73:1095–105.
Dowd FJ, Johnson BS, Mariotti AJ. Pharmacology and therapeutics for dentistry. (No Title). 2017.
Capocci M, Romeo U, Guerra F, Mannocci A, Tenore G, Annibali S, et al. Medication-related osteonecrosis of the jaws (MRONJ) and quality of life evaluation: a pilot study. La Clin Terapeutica. 2017;168:e253–e7.
Akbari H, Hannani M, Motalebi Kashani M, Sadaf M, Saberi HR, Bidgoli SD, et al. Measurement of barriers to perform periodic examinations: development and psychometric properties scale. Int J Occup Saf Ergonomics. 2023;29:941–9.
Bollen KA. Structural equations with latent variables: John Wiley & Sons; 1989.
Fornell C, Larcker DF. Evaluating structural equation models with unobservable variables and measurement error. J Mark Res. 1981;18:39–50.
Hair JF, Black WC, Babin BJ, Anderson RE, Tatham RL. Multivariate data analysis 6th Edition. Pearson Prentice Hall. New Jersey. Humans: Critique and reformulation …; 2006.
Al-Maweri SA, Alshammari MN, Alharbi AR, Bahein AA, Alhajj MN, Al-Shamiri HM, et al. Knowledge and opinions of Saudi dentists regarding dental treatment of patients undergoing bisphosphonates. Eur J Dent. 2020;14:144–51.
de Lima PB, Brasil VLM, de Castro JFL, de Moraes Ramos-Perez FM, Alves FA, dos Anjos Pontual ML, et al. Knowledge and attitudes of Brazilian dental students and dentists regarding bisphosphonate-related osteonecrosis of the jaw. Support Care Cancer. 2015;23:3421–6.
Yazdani J, Mortazavi A, Abbasi E. Knowledge of Tabriz dentists about bisphosphonate-related osteonecrosis of the Jaw in 2015. Med J Tabriz Univ Med Sci. 2019;41:101–5.
de Souza TAM, Zucco GR, Almeida JD. Knowledge of Brazilian dentists about bisphosphonate-associated osteonecrosis of the jaw. Brazilian Dental Sci. 2024;27.
Hayes KN, Winter EM, Cadarette SM, Burden AM. Duration of bisphosphonate drug holidays in osteoporosis patients: a narrative review of the evidence and considerations for decision-making. J Clin Med. 2021;10:1140.
Işık G, Yüce MÖ, Koyuncu BÖ, Mandıracıoğlu A. Medication-Related Osteonecrosis of the Jaw: Awareness and Level of Knowledge of Turkish Physicians. 2022.
Khosla S, Burr D, Cauley J, Dempster DW, Ebeling PR, Felsenberg D, et al. Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. John Wiley and Sons and The American Society for Bone and Mineral Research …; 2007. p.1479-91.
Lam DK, Sándor GK, Holmes HI, Evans AW, Clokie CM. A review of bisphosphonate-associated osteonecrosis of the jaws and its management. Journal of the Canadian Dental Association. 2007;73:417–22.
Albu-Stan I-A, Petrovan C, Cerghizan D, Eremie LY, Crăciun AE, Copotoiu C. Knowledge and attitude of dentists regarding patients undergoing bisphosphonate treatment: a comparative questionnaire. J Interdiscip Med. 2018;3:169–72.
Jakiel J, Jenda D, Rahnama M Prophylaxis of medication-related necrosis of the jaws in dental patients–study of 49 cases. J Pre-Clinical Clin Res. 2018;12.
Author information
Authors and Affiliations
Department of Statistics and Epidemiology, Kerman University of Medical Sciences, Kerman, Iran
Fahimeh Karamali
Department of Oral and Maxillofacial Surgery & Periodontics, School of Dentistry, Kashan University of Medical Sciences, Kashan, Iran
Amirsalar SeyedYahossein
Department of Dentistry, Kashan University of Medical Sciences, Kashan, Iran
Shahrzad Ahmadi
Trauma Research Center, Kashan University of Medical Sciences, Kashan, Iran
Faezeh Asgari
Social Determinants of Health (SDH) Research Center, Kashan University of Medical Sciences, Kashan, Iran
Hossein Akbari
Authors
- Fahimeh Karamali
- Amirsalar SeyedYahossein
- Shahrzad Ahmadi
- Faezeh Asgari
- Hossein Akbari
Corresponding author
Correspondence to Hossein Akbari.
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Karamali, F., SeyedYahossein, A., Ahmadi, S. et al. Design and validation of a questionnaire to measure the knowledge and performance of dentists regarding dental considerations in patients receiving bisphosphonate. BDJ Open 12, 116 (2026). https://doi.org/10.1038/s41405-026-00443-y
Received: 22 May 2025
Revised: 29 December 2025
Accepted: 29 December 2025
Published: 19 November 2026
Version of record: 19 November 2026
DOI: https://doi.org/10.1038/s41405-026-00443-y
来源:Nature 健康护理主题 · nature.com